JP2023536437A5 - - Google Patents
Info
- Publication number
- JP2023536437A5 JP2023536437A5 JP2023504833A JP2023504833A JP2023536437A5 JP 2023536437 A5 JP2023536437 A5 JP 2023536437A5 JP 2023504833 A JP2023504833 A JP 2023504833A JP 2023504833 A JP2023504833 A JP 2023504833A JP 2023536437 A5 JP2023536437 A5 JP 2023536437A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- erap2
- mhc
- hla
- inhibitor according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063056562P | 2020-07-25 | 2020-07-25 | |
| US63/056,562 | 2020-07-25 | ||
| US202163171672P | 2021-04-07 | 2021-04-07 | |
| US63/171,672 | 2021-04-07 | ||
| PCT/US2021/043062 WO2022026336A1 (en) | 2020-07-25 | 2021-07-23 | Modulation of endoplasmic reticulum aminopeptidase 2 (erap2)-mediated immune response |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023536437A JP2023536437A (ja) | 2023-08-25 |
| JP2023536437A5 true JP2023536437A5 (cg-RX-API-DMAC7.html) | 2024-07-30 |
Family
ID=77564145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023504833A Pending JP2023536437A (ja) | 2020-07-25 | 2021-07-23 | 小胞体アミノペプチダーゼ２（ｅｒａｐ２）媒介性免疫応答の調節 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230059929A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4188963A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023536437A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230043888A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116194484A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021316196B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3189755A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL299986A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023001059A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022026336A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4416286A1 (en) | 2021-10-14 | 2024-08-21 | Regeneron Pharmaceuticals, Inc. | Treatment of uveitis with endoplasmic reticulum aminopeptidase 1 (erap1) inhibitors |
| US12613286B2 (en) | 2024-01-22 | 2026-04-28 | Garrett Transportation I Inc. | System and method for battery parameter recharacterization |
| CN118593462B (zh) * | 2024-06-28 | 2026-01-27 | 沈阳药科大学 | 鼠尾草酸作为erap1的抑制剂在制备治疗强直性脊柱炎药物中的应用 |
-
2021
- 2021-07-23 IL IL299986A patent/IL299986A/en unknown
- 2021-07-23 JP JP2023504833A patent/JP2023536437A/ja active Pending
- 2021-07-23 EP EP21763171.2A patent/EP4188963A1/en active Pending
- 2021-07-23 CN CN202180052000.4A patent/CN116194484A/zh active Pending
- 2021-07-23 WO PCT/US2021/043062 patent/WO2022026336A1/en not_active Ceased
- 2021-07-23 CA CA3189755A patent/CA3189755A1/en active Pending
- 2021-07-23 AU AU2021316196A patent/AU2021316196B2/en active Active
- 2021-07-23 US US17/384,601 patent/US20230059929A1/en active Pending
- 2021-07-23 KR KR1020237005322A patent/KR20230043888A/ko active Pending
- 2021-07-23 MX MX2023001059A patent/MX2023001059A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lyons et al. | Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status | |
| JP2023536437A5 (cg-RX-API-DMAC7.html) | ||
| AU2016281772B2 (en) | Detection of chromosome interactions | |
| Merkel et al. | Identification of functional and expression polymorphisms associated with risk for antineutrophil cytoplasmic autoantibody–associated vasculitis | |
| Stone et al. | IgG4-related disease | |
| EP3202914B2 (en) | Method for treating a neurodegenerative disease | |
| Puthia et al. | IRF7 inhibition prevents destructive innate immunity—A target for nonantibiotic therapy of bacterial infections | |
| El-Far et al. | Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressors | |
| FI3774897T3 (fi) | Menetelmiä ja järjestelmiä tulehdustautisten potilaiden valintaan ja hoitoon | |
| US12188081B2 (en) | Bioinformatics methods of in silico validation and selection of circRNAs | |
| Frade et al. | Polymorphism in the alpha cardiac muscle actin 1 gene is associated to susceptibility to chronic inflammatory cardiomyopathy | |
| EP3538891A2 (en) | Compositions and methods for the simultaneous genomic, transcriptomic and proteomic analysis of single cells | |
| Abe‐Hatano et al. | Whole genome sequencing of 45 Japanese patients with intellectual disability | |
| Lim et al. | Exome sequencing identifies KIAA1377 and C5orf42 as susceptibility genes for monomelic amyotrophy | |
| Turkunova et al. | Molecular genetics and pathogenesis of the floating harbor syndrome: case report of long-term growth hormone treatment and a literature review | |
| Friebus-Kardash et al. | Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritis | |
| Hsu et al. | Effect of resistance training on satellite cells in old mice–a transcriptome study: Implications for sarcopenia | |
| Schramm et al. | Interaction dynamics between innate and adaptive immune cells responding to SARS-CoV-2 vaccination in non-human primates | |
| JP2024515240A5 (cg-RX-API-DMAC7.html) | ||
| EP3013976B1 (en) | Method of predicting risk for type 1 diabetes before seroconversion | |
| Gardet et al. | Pristane-accelerated autoimmune disease in (SWR X NZB) F1 mice leads to prominent tubulointerstitial inflammation and human lupus nephritis-like fibrosis | |
| Milazzo et al. | UBE3A reinstatement restores behaviorand proteome in an Angelman syndrome mouse model of imprinting defects | |
| Ismail | Bioinformatics of Autoimmune Diseases | |
| Zhang et al. | Associations of 2,922 genetically predicted plasma protein levels with mental illness and response to treatment | |
| Meijer et al. | A primed immune transcriptional program is activated in oligodendroglia in multiple sclerosis |